CNChina Nagano

China Nagano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


China Nagano has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Potentially protein-destabilizing C3 polymorphism in a case of atypical hemolytic uremic syndrome with life-threatening extrarenal manifestations

    by Takuji Enya, Kohei Miyazaki, Sakina Kuge, Yuichi Morimoto, Hiroki Kondou, Naoki Sakata, Kensuke Joh, China Nagano, Nobutoshi Ito, Yoshiyuki Hakata, et al.

    Background: Atypical hemolytic uremic syndrome (aHUS) is a rare, life-threatening disease caused by uncontrolled complement activation. It is frequently associated with a genetic factor including various polymorphisms at the C3 gene locus; however, no functional amino acid substitution in the C-terminal domain has been reported. We experienced a pediatric case of aHUS with multisystem involvements including refractory hypertension and gastrointestinal bleeding in which immunohistochemical, genetic, and molecular structural analyses were performed. Methods: Biopsy specimens were stained for renin and C5b-9. Serum factor Ba levels were measured to evaluate the alternative pathway activation. Genomic DNA was obtained with consent for targeted Sanger sequencing. The possible effects of the identified amino acid substitution on the molecular structure of C3 were analyzed by computer-aided simulation. Results: Immunostaining revealed intense renin staining in the hyperplastic juxtaglomerular apparatus. Endothelial cells of renal and intestinal blood vessels were positive for C5b-9. Serum Ba level in the active phase was higher than control level. Genetic analyses showed a C3 polymorphism resulting in M1604T substitution in the C345C domain. Although previously reported to be a variant of unknown significance, molecular structural analysis indicated that this amino acid substitution results in the formation of a large space within the hydrophobic core of the C-terminal domain, possibly destabilizing the spherical structure of C3. Renin-angiotensin system inhibitors for refractory hypertension were effective in this patient. Conclusions: M1604T substitution in the C345C domain of C3 molecule may functionally underlie the observed life-threatening extrarenal manifestations.